FINANCIAL RESULTS & EVENTS
MMMM D, YYYY

Investor presentations

2021

2021-06-04MMMM D, YYYY
Sanofi @ ASCO 2021
ACCESS ALL INFORMATION
2021-02-05MMMM D, YYYY
Capital Markets Day 2021
ACCESS ALL INFORMATION

2020

2020-08-17MMMM D, YYYY
IR call on the acquisition of Principia Biopharma Inc.
ACCESS ALL INFORMATION
2020-07-30MMMM D, YYYY
R&D DAYS 5/5: Nirsevimab R&D investor event
ACCESS ALL INFORMATION
2020-06-23MMMM D, YYYY

R&D DAYS 4/5: Virtual R&D Day investor event

ACCESS ALL INFORMATION
2020-06-11MMMM D, YYYY
R&D DAYS 3/5: Dupixent® R&D investor event
ACCESS ALL INFORMATION
2020-06-02MMMM D, YYYY
R&D DAYS 2/5: Oncology strategy and ASCO R&D investor event
ACCESS ALL INFORMATION
2020-04-23MMMM D, YYYY
R&D DAYS 1/5: BTKi ('168) R&D investor event
ACCESS ALL INFORMATION
2020-03-27MMMM D, YYYY
IR call: Sanofi expands collaboration with Translate Bio to develop mRNA COVID-19 vaccine
ACCESS ALL INFORMATION
2020-02-24MMMM D, YYYY
IR call: Sanofi to create new industry leading European company to provide APIs
ACCESS ALL INFORMATION

2019

Sanofi offices Cambridge.
2019-12-10MMMM D, YYYY
Capital Markets Day
ACCESS ALL INFORMATION

2018

media/Project/One-Sanofi-Web/sanofi-com/common/img/investors/bloc_2018_investor_presentations_Ircall_March2018.jpg
2018-03-10MMMM D, YYYY
IR conference call on Odyssey Outcomes
Access all information
IR call on the acquisition of Ablynx
2018-01-29MMMM D, YYYY
IR call on the acquisition of Ablynx
Access all information
IR call on the acquisition of Bioverativ Inc
2018-01-22MMMM D, YYYY
IR call on the acquisition of Bioverativ Inc.
Access all information

2017

Sustaining Innovation Analyst Day
2017-12-13MMMM D, YYYY
Sustaining Innovation Analyst Day
Access all information
Dupixent® FDA approval call
2017-03-28MMMM D, YYYY
Dupixent® FDA approval call
Access all information

2016

IR thematic call on dupilumab
2016-10-01MMMM D, YYYY
IR thematic call on dupilumab
Access all information
IR thematic call – Building global leadership in Consumer Healthcare
2016-06-27MMMM D, YYYY

Sanofi organized a conference call following the signing of contracts with Boehringer Ingelheim.

Access all information

2015

IR thematic call on sarilumab
2015-11-09MMMM D, YYYY
IR thematic call on sarilumab

Sanofi and Regeneron hosted a conference call on sarilumab.

Access all information
Meet Sanofi Management
2015-11-06MMMM D, YYYY
Meet Sanofi Management

Sanofi organized a Meet Management Seminar focusing on its strategic roadmap 2020.

Access all information
IR thematic call on Praluent® FDA approval
2015-07-24MMMM D, YYYY
IR thematic call on Praluent® FDA approval

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

Access all information
IR thematic call on Diabetes
2015-06-09MMMM D, YYYY
IR thematic call on Diabetes

Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.

Access all information

2014

IR thematic seminar on New Medicines
2014-11-20MMMM D, YYYY
IR thematic seminar on New Medicines

Sanofi hosted an IR Thematic Seminar on New Medicines.

Access all information
IR thematic call with Serge Weinberg
2014-10-29MMMM D, YYYY
IR thematic call with Serge Weinberg

Sanofi held a conference call with Serge Weinberg for the financial community.

Access all information
IR thematic call on alirocumab
2014-09-02MMMM D, YYYY
IR thematic call on alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the European Society of Cardiology Congress in Barcelona.

Access all information
TIR thematic call on Diabetes
2014-06-16MMMM D, YYYY
IR thematic call on Diabetes

Sanofi hosted a Thematic Conference Call on Diabetes in connection with the American Diabetes Association's Scientific Sessions.

Access all information
IR thematic call on alirocumab
2014-03-31MMMM D, YYYY
IR thematic call on alirocumab

Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the American College of Cardiology Annual Meeting.

Access all information

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK